This could be what determines if you get a mild or severe coronavirus case

$%name This could be what determines if you get a mild or severe coronavirus case by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

A protein called suPAR might be a reliable indicator of whether or not COVID-19 patients will develop severe respiratory problems.
Higher levels of the protein in plasma were associated with a shorter time to intubation in patients who contracted the novel coronavirus and developed a severe case of the disease.
More research may be required but if these findings are confirmed, suPAR may become a marker for the severity of the disease.
Visit BGR’s homepage for more stories.

Remdesivir will become a standard drug for COVID-19 therapy, as current research indicates the medicine that was initially developed for Ebola can reduce the recovery time in patients. Remdesivir isn’t a miracle drug that can prevent the infection, and it can’t reduce mortality. In the absence of a perfect medicine that could reduce the risk of developing complications, or of a vaccine that can prevent novel coronavirus infections altogether, we could benefit from a different tool to help patients. That’s some sort of a marker that might warn doctors of which COVID-19 patients are most likely to develop severe respiratory issues that could ultimately lead to death. Now, a new study claims that such a marker already exists.

Continue reading…

Today’s Top Deals

Trending Right Now:

This could be what determines if you get a mild or severe coronavirus case originally appeared on BGR.com on Wed, 6 May 2020 at 13:56:55 EDT. Please see our terms for use of feeds.